Visitor registration for the 23rd China International In Vitro Diagnostic Expo by CACLP is now officially open.

As part of promotional activities leading up to CACLP 2026, a series of activities took place successfully in Xiamen last week. Among them, the Xiamen Forum on Empowering the In Vitro Diagnostics Industry and Exploring New Models of Collaboration was held on 21 November 2025.

I. Policy and Background 2015 is a year that medical and health-related policies are disseminated more. These changes in policy and background have promoted the development of the In Vitro diagnostics industry, urged the industry corporate

If exhibitioners needbookinghotel during the Expo, please complete hotel reservation receipt form and below is our charging standard. Hotel Name Room Style Price [1] Address Remarks Wyndham Chongqing Yuelai Hotel Suite $228 No.88 Binjiang A

Nanchang Greenland International Expo Center, China Address: No. 1315, Huai-yu Mountains (Huaiyu Shan) Avenue, New District of Honggu Tan, Nanchang, China. 4 km to Nanchang West Station; 16 km to Nanchang Station 36.5 km from Changbei Airpo

Nanchang Greenland International Expo Center, China Address: No. 1315, Huai-yu Mountains (Huaiyu Shan) Avenue, New District of Honggu Tan, Nanchang, China. 4 km to Nanchang West Station; 16 km to Nanchang Station 36.5 km from Changbei Airpo

2020 The 5th Chinese Experimental Medicine Conference (CEMC) / Wiley Conference on In Vitro Diagnostics is going to be hosted from March 27th to 29th, at Primus Hotel Nanchang International Expo City.

Organized by Broad (Shanghai) Exhibition Business Co., Ltd., CACLP Expo 2019 is going to be hosted from March 20 th to 24 th at Nanchang Greenland International Expo Center. Again it`s the annual get-together time for our IVD industry, again

NEW YORK (GenomeWeb) Bruker said on Thursday that it has acquired Berlin-based JPK Instruments for an undisclosed amount. JPK provides microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single

雅培Q2有机Dx收入增长7％Abbott Q2 Organic Dx Revenues Rise 7 Percent Abbott recentlysaid that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business,